Kobayashi, T., Iwama, S., Yasuda, Y., Okada, N., Okuji, T., Ito, M., . . . Arima, H. (2020). Pituitary dysfunction induced by immune checkpoint inhibitors is associated with better overall survival in both malignant melanoma and non-small cell lung carcinoma: A prospective study. J Immunother Cancer.
Chicago Style citaatKobayashi, Tomoko, et al. "Pituitary Dysfunction Induced By Immune Checkpoint Inhibitors Is Associated With Better Overall Survival in Both Malignant Melanoma and Non-small Cell Lung Carcinoma: A Prospective Study." J Immunother Cancer 2020.
MLA citatieKobayashi, Tomoko, et al. "Pituitary Dysfunction Induced By Immune Checkpoint Inhibitors Is Associated With Better Overall Survival in Both Malignant Melanoma and Non-small Cell Lung Carcinoma: A Prospective Study." J Immunother Cancer 2020.